Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Article
Ask The Pharmacist: CGRP Therapies for Migraine Management in Workers' Compensation
How can CGRP therapies improve outcomes in workers’ compensation migraine claims?Migraines affect around one
Workers' Comp
Article
Migraine Medication Trends in Work Comp
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our
Workers' Comp
Podcast
Calculating the Value of Evidence-Based PT
Workers' Comp
Conference
Workers’ Compensation Institute (WCI) 2025 Conference
Enlyte is proud to return as an Elite Sponsor at the 2025 Workers' Compensation Institute (WCI) Conference in Orlando, Florida—th
Workers' Comp
Article
Reclaim Control Over Specialty Costs
The Growing Surge in Specialty Service CostsAs specialty services become a major driver of rising expenses, effective management of medica
Workers' Comp
Article
Revolutionizing Specialty Services Management
The Hidden Costs of Administrative ComplexityManaging specialty services claims is a balancing act.